Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bendazac L-lysine (Bendazaco lisina) is an agent introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | In stock | $ 30.00 | |
100 mg | In stock | $ 39.00 | |
200 mg | In stock | $ 55.00 | |
500 mg | In stock | $ 91.00 |
Description | Bendazac L-lysine (Bendazaco lisina) is an agent introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention. |
Synonyms | Bendazac lysine, Bendazaco lisina |
Molecular Weight | 428.48 |
Formula | C22H28N4O5 |
CAS No. | 81919-14-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2.41 mg/mL (5.62 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bendazac L-lysine 81919-14-4 Others Inhibitor inhibit Bendazac lysine Bendazaco lisina Bendazac Llysine Bendazac L lysine Bendazac inhibitor